Pancreatic cancer surgery.
作者信息
Di Martino Marcello, El Boghdady Michael
机构信息
AORN, Cardarelli, Italy.
Guy's and St Thomas' NHS Foundation Trust, London, UK.
出版信息
BMC Surg. 2023 Jul 7;23(1):196. doi: 10.1186/s12893-023-02091-7.
Abstract
摘要
相似文献
1
Pancreatic cancer surgery.胰腺癌手术
BMC Surg. 2023 Jul 7;23(1):196. doi: 10.1186/s12893-023-02091-7.
2
Show us the money: role of pancreatectomy and vascular reconstruction in pancreatic cancer in the coming era of value-based payment.给我们看看钱：在即将到来的基于价值支付的时代，胰腺切除术和血管重建在胰腺癌治疗中的作用。
JAMA Surg. 2013 Apr;148(4):339. doi: 10.1001/jamasurg.2013.1068.
3
Duodenum and ventral pancreas preserving subtotal pancreatectomy for low-grade malignant neoplasms of the pancreas: An alternative procedure to total pancreatectomy for low-grade pancreatic neoplasms.十二指肠和胰体尾联合切除术保留部分胰腺治疗胰腺低度恶性肿瘤：一种治疗胰腺低度肿瘤的替代全胰切除术的术式。
World J Gastroenterol. 2017 Sep 21;23(35):6457-6466. doi: 10.3748/wjg.v23.i35.6457.
4
[The place of total pancreatectomy in cancer of the head of the pancreas].[全胰切除术在胰头癌治疗中的地位]
Acta Chir Belg. 1983 Mar-Apr;83(2):89-94.
5
Robotic middle pancreatectomy with the double pursestring invaginated pancreaticogastrostomy (with video).采用双重荷包内翻胰胃吻合术的机器人胰体尾切除术（附视频）
J Visc Surg. 2016 Dec;153(6):475-476. doi: 10.1016/j.jviscsurg.2016.05.017. Epub 2016 Jun 29.
6
Transecting the pancreas neck with electrothermal bipolar vessel sealer (LigaSure) in laparoscopic left pancreatectomy: case report.
Surg Laparosc Endosc Percutan Tech. 2009 Oct;19(5):e175-6. doi: 10.1097/SLE.0b013e3181b8fb3c.
7
[III. Resection Margins and R1 Resection in Pancreatic Cancer].
Gan To Kagaku Ryoho. 2018 Oct;45(10):1428-1430.
8
Current practice in pancreatic surgery.
Adv Exp Med Biol. 2006;574:111-43. doi: 10.1007/0-387-29512-7_13.
9
What indication, morbidity and mortality for central pancreatectomy in oncological surgery? A systematic review.肿瘤外科中胰体尾切除术的适应证、发病率和死亡率如何？一项系统评价。
Int J Surg. 2016 Apr;28 Suppl 1:S172-6. doi: 10.1016/j.ijsu.2015.12.046. Epub 2015 Dec 18.
10
[Surgery of the pancreas].[胰腺手术]
Magy Seb. 2008 Dec;61(6):381-9. doi: 10.1556/MaSeb.61.2008.6.10.
引用本文的文献
1
The role and therapeutic value of NUSAP1 in human cancers.NUSAP1在人类癌症中的作用及治疗价值。
J Transl Med. 2025 Jul 2;23(1):725. doi: 10.1186/s12967-025-06746-2.
2
S-1/irinotecan/oxaliplatin chemotherapy achieved a pathological complete remission in advanced pancreatic carcinoma.S-1/伊立替康/奥沙利铂化疗使晚期胰腺癌实现了病理完全缓解。
Clin J Gastroenterol. 2025 Feb;18(1):220-223. doi: 10.1007/s12328-024-02055-1. Epub 2024 Nov 6.
3
PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway.PABPC1基因沉默抑制胰腺癌细胞增殖和上皮-间质转化，并通过PI3K/AKT信号通路诱导细胞凋亡。
Cytotechnology. 2024 Jun;76(3):351-361. doi: 10.1007/s10616-024-00626-1. Epub 2024 Apr 22.
4
Prognostic Model Construction of Disulfidptosis-Related Genes and Targeted Anticancer Drug Research in Pancreatic Cancer.胰腺癌中双硫死亡相关基因的预后模型构建及靶向抗癌药物研究
Mol Biotechnol. 2025 Apr;67(4):1463-1482. doi: 10.1007/s12033-024-01131-8. Epub 2024 Apr 4.
5
Short-Term Outcomes of Conventional Laparoscopic versus Robot-Assisted Distal Pancreatectomy for Malignancy: Evidence from US National Inpatient Sample, 2005-2018.传统腹腔镜手术与机器人辅助远端胰腺切除术治疗恶性肿瘤的短期疗效：来自美国国家住院患者样本（2005 - 2018年）的证据
Cancers (Basel). 2024 Feb 29;16(5):1003. doi: 10.3390/cancers16051003.
本文引用的文献
1
Quality of Life in Patients with Pancreatic Cancer-A Literature Review.胰腺癌患者的生活质量——文献综述。
Int J Environ Res Public Health. 2023 Mar 10;20(6):4895. doi: 10.3390/ijerph20064895.
2
Efficient and accurate KRAS genotyping using digital PCR combined with melting curve analysis for ctDNA from pancreatic cancer patients.利用数字 PCR 结合熔解曲线分析检测胰腺癌患者 ctDNA 中的 KRAS 基因突变：一种高效准确的方法。
Sci Rep. 2023 Feb 21;13(1):3039. doi: 10.1038/s41598-023-30131-y.
3
Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An International, Retrospective, Cohort Study.机器人辅助与腹腔镜下胰体尾切除术治疗可切除胰腺癌患者的国际回顾性队列研究。
Ann Surg Oncol. 2023 May;30(5):3023-3032. doi: 10.1245/s10434-022-13054-2. Epub 2023 Feb 17.
4
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R).伊匹单抗、纳武单抗和托珠单抗联合立体定向体部放疗治疗难治性胰腺癌的2期研究（TRIPLE-R）
Eur J Cancer. 2023 Feb;180:125-133. doi: 10.1016/j.ejca.2022.11.035. Epub 2022 Dec 10.
5
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.在可切除边缘的胰腺癌患者中，即刻手术与短程新辅助吉西他滨联合卡培他滨、FOLFIRINOX或放化疗的比较（ESPAC5）：一项四臂、多中心、随机、2期试验
Lancet Gastroenterol Hepatol. 2023 Feb;8(2):157-168. doi: 10.1016/S2468-1253(22)00348-X. Epub 2022 Dec 12.
6
Adjuvant -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial.辅助 - 紫杉醇 + 吉西他滨治疗切除术后胰腺导管腺癌：一项随机、开放标签、III 期临床试验的结果。
J Clin Oncol. 2023 Apr 10;41(11):2007-2019. doi: 10.1200/JCO.22.01134. Epub 2022 Dec 15.
7
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.FOLFIRINOX 对比吉西他滨作为胰腺癌辅助治疗的 5 年结果：一项随机临床试验。
JAMA Oncol. 2022 Nov 1;8(11):1571-1578. doi: 10.1001/jamaoncol.2022.3829.
8
Postoperative Serum Hyperamylasemia Adds Sequential Value to the Fistula Risk Score in Predicting Pancreatic Fistula after Pancreatoduodenectomy.术后血清高淀粉酶血症在预测胰十二指肠切除术后胰瘘方面为瘘风险评分增加了连续价值。
Ann Surg. 2023 Aug 1;278(2):e293-e301. doi: 10.1097/SLA.0000000000005629. Epub 2022 Jul 25.
9
Perioperative interventions to reduce pancreatic fistula following pancreatoduodenectomy: meta-analysis.胰十二指肠切除术后减少胰瘘的围手术期干预：荟萃分析。
Br J Surg. 2022 Aug 16;109(9):812-821. doi: 10.1093/bjs/znac074.
10
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.可切除和边缘可切除胰腺癌的新辅助放化疗与 upfront 手术比较：荷兰随机 PREOPANC 试验的长期结果。
J Clin Oncol. 2022 Apr 10;40(11):1220-1230. doi: 10.1200/JCO.21.02233. Epub 2022 Jan 27.
Zotero 插件